Discontinued — last reported Q3 '25
DexCom Intangibles (Net) decreased by 11.6% to $62.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 34.2%, from $95.20M to $62.60M. Over 4 years (FY 2021 to FY 2025), Intangibles (Net) shows an upward trend with a 22.4% CAGR.
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_net| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.50M | $31.40M | $28.00M | $24.40M | $173.30M | $163.60M | $154.20M | $144.50M | $134.50M | $123.30M | $114.50M | $106.20M | $103.40M | $95.20M | $87.20M | $79.00M | $70.80M | $62.60M |
| QoQ Change | — | -0.3% | -10.8% | -12.9% | +610.2% | -5.6% | -5.7% | -6.3% | -6.9% | -8.3% | -7.1% | -7.2% | -2.6% | -7.9% | -8.4% | -9.4% | -10.4% | -11.6% |
| YoY Change | — | — | — | — | +450.2% | +421.0% | +450.7% | +492.2% | -22.4% | -24.6% | -25.7% | -26.5% | -23.1% | -22.8% | -23.8% | -25.6% | -31.5% | -34.2% |